Join the Coronary Artery Disease (CAD) group to help and get support from people like you.
Coronary Artery Disease (CAD) News (Page 3)
Related terms: Arteriosclerotic Heart Disease, Coronary Heart Disease (CHD), Coronary Heart Disease, CAD, CHD
CHD Risk Increased for Men Exposed to Work Strain, Effort-Reward Imbalance
FRIDAY, Sept. 22, 2023 – Men exposed to job strain or effort-reward imbalance (ERI) have an increased risk for coronary heart disease (CHD), according to a study published online Sept. 19 in...
High-Intensity Statins Underused With Atherosclerotic Cardiovascular Disease
TUESDAY, Sept. 19, 2023 – Among patients with atherosclerotic cardiovascular disease (ASCVD), high-intensity statins are underutilized in routine care, according to a study published online Aug. 2...
Job Frustrations Can Really Be a Heartbreaker for Men
TUESDAY, Sept. 19, 2023 – A job that's demanding but less than rewarding may take a big toll on a man's heart health, a large new study suggests. The study, of nearly 6,500 white-collar workers,...
Opening All Arteries Best When Heart Attack Strikes in Old Age: Study
MONDAY, Aug. 28, 2023 – After a heart attack, elderly adults have better odds for improved health and survival if all major heart vessels are cleared, not just the one that caused the heart attack....
Aspirin Underused in Secondary Prevention of Cardiovascular Disease
THURSDAY, Aug. 24, 2023 – Aspirin is underused in secondary prevention of cardiovascular disease (CVD), according to a study published online Aug. 22 in the Journal of the American Medical...
Heterogeneity Found in Appropriate Use Criteria for Imaging of CAD
WEDNESDAY, Aug. 23, 2023 – U.S. Centers for Medicare & Medicaid Services (CMS)-qualified Appropriate Use Criteria (AUC) for imaging of coronary artery disease (CAD) are heterogeneous and discrepant,...
Cardiac Rehab Lowers Risk for Death After Coronary Artery Bypass Grafting
WEDNESDAY, Aug. 2, 2023 – Cardiac rehabilitation (CR) is associated with lower two-year mortality following coronary artery bypass grafting (CABG), according to a study published online June 29 in...
FDA Approves Norliqva (amlodipine) Oral Solution for Hypertension and Coronary Artery Disease
February 28, 2022 - The U.S. Food and Drug Administration has approved Norliqva (amlodipine) oral solution for the treatment of: Hypertension in adults and children 6 years and older, to lower blood...
Brilinta Approved in the US to Reduce the Risk of a First Heart Attack or Stroke in High-Risk Patients with Coronary Artery Disease
June 1, 2020 – AstraZeneca’s Brilinta (ticagrelor) has been approved in the US to reduce the risk of a first heart attack or stroke in high-risk patients with coronary artery disease (CAD), the most ...
FDA Approves Gadavist (gadobutrol) Contrast Agent for Use in Cardiac MR in Adult Patients with Known or Suspected Coronary Artery Disease
WHIPPANY, N.J., July 15, 2019 /PRNewswire/ – Bayer announced today the U.S. Food and Drug Administration (FDA) has approved Gadavist (gadobutrol) injection for use in cardiac magnetic resonance (MR)...
FDA Approves Katerzia (amlodipine) Oral Suspension for Pediatric Patients 6 Years of Age and Older
WOBURN, Mass. (July 10, 2019) – Azurity Pharmaceuticals, a specialty pharmaceutical company that makes safe, high-quality treatments for patients requiring customized formulations for their care, ann...
FDA Approves Xarelto to Reduce the Risk of Major Cardiovascular Events in Patients with Chronic Coronary Artery Disease (CAD) or Peripheral Artery Disease (PAD)
TITUSVILLE, NJ, October 11, 2018 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that the U.S. Food and Drug Administration (FDA) has approved Xarelto (rivaroxaban) to r...
Ask a question
To post your own question to this support group, sign in or create an account.
Further information
Related drug support groups
lisinopril, amlodipine, Xarelto, Brilinta, Norvasc, garlic, ticagrelor